Avecho

Cannabis Stock Roundup: Avecho Surpasses Enrolment Target, Argent Ships CannEpil to Ireland, Neurotech Addresses Funding Queries

Finance

Cannabis Stock Roundup: Avecho Surpasses Enrolment Target, Argent Ships CannEpil to Ireland, Neurotech Addresses Funding Queries

April 29, 2026

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

Medical

Avecho CEO confident ahead of CBD insomnia trial's pivotal interim results

March 26, 2026

Avecho reaches recruitment milestone in CBD insomnia trial ahead of June results

Medical

Avecho reaches recruitment milestone in CBD insomnia trial ahead of June results

March 04, 2026

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

Finance

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

February 02, 2026

Finance Roundup: Elixinol defends cash position; Aurora posts record quarter with Australian boost; Avecho secures funding and stays on trial schedule; Cann Group wins NAB deadline extension; InhaleRx keeps spending tight

Finance

Finance Roundup: Elixinol defends cash position; Aurora posts record quarter with Australian boost; Avecho secures funding and stays on trial schedule; Cann Group wins NAB deadline extension; InhaleRx keeps spending tight

November 04, 2025

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

Medical

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

August 29, 2025

Shahin Takes Top Stake in Vitura; Avecho, Epsilon and Zelira Post Key Updates

Medical

Shahin Takes Top Stake in Vitura; Avecho, Epsilon and Zelira Post Key Updates

July 31, 2025

Board Members Buy Into Cann Group as AusCann, Emyria and Avecho Report Changes

Finance

Board Members Buy Into Cann Group as AusCann, Emyria and Avecho Report Changes

June 13, 2024

Avecho Enrolls First Patient in Pivotal Phase III CBD Insomnia Study

Medical

Avecho Enrolls First Patient in Pivotal Phase III CBD Insomnia Study

May 16, 2024

Avecho's CBD Capsule Passes Two-Year Stability Test Ahead of Insomnia Trial

Medical

Avecho's CBD Capsule Passes Two-Year Stability Test Ahead of Insomnia Trial

June 23, 2023

Avecho Seeks Fresh Investment to Bridge Gap in CBD Trial Funding Drive

Finance

Avecho Seeks Fresh Investment to Bridge Gap in CBD Trial Funding Drive

May 09, 2023

Quarterly Financial Updates: Avecho, Elixinol, Epsilon and Creso Pharma

Finance

Quarterly Financial Updates: Avecho, Elixinol, Epsilon and Creso Pharma

May 02, 2023

Half-Year and Full-Year Financial Roundup: Elixinol, Emyria, Epsilon, Avecho, Creso Pharma, AusCann, MGC Pharma, Botanix, Zelira

Finance

Half-Year and Full-Year Financial Roundup: Elixinol, Emyria, Epsilon, Avecho, Creso Pharma, AusCann, MGC Pharma, Botanix, Zelira

March 01, 2023

Lambert Initiative to Investigate Avecho CBD Capsules Across Two New Clinical Trials

Medical

Lambert Initiative to Investigate Avecho CBD Capsules Across Two New Clinical Trials

February 22, 2023

Industry Updates: Avecho, Levin Health, Cannatrek, Releaf Group, Bod Science

Legal

Industry Updates: Avecho, Levin Health, Cannatrek, Releaf Group, Bod Science

December 22, 2022

Avecho CEO flags placebo effect as key hurdle for OTC CBD registration bids

Medical

Avecho CEO flags placebo effect as key hurdle for OTC CBD registration bids

October 20, 2022

Avecho's TPM CBD Formula Outperforms Epidyolex on Absorption in Dog Study

Medical

Avecho's TPM CBD Formula Outperforms Epidyolex on Absorption in Dog Study

September 19, 2022

Medical

Avecho begins observational study to test oral CBD formulation on human patients

January 04, 2021